Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 32 Pain, Postoperative 18 Neoplasms 15 Parkinson Disease 4, Autosomal Dominant Lewy Body 13 Lung Neoplasms 12 Brain Neoplasms 12 Prostatic Neoplasms 9 Ovarian Neoplasms 8 Colonic Neoplasms 8 Carcinoma, Hepatocellular 8 Stomach Neoplasms 7 Depression 7 Colorectal Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Pain 6 Head and Neck Neoplasms 6 Thyroid Neoplasms 5 Pancreatic Neoplasms 5 Multiple Myeloma 5 Leiomyoma 5 Agnosia 5 Neoplasm Metastasis 4 Lymphoma 4 Fatigue 4 Delirium 4 Anxiety Disorders 4 Urinary Bladder Neoplasms 3 Thromboembolism 3 Supratentorial Neoplasms 3 Stomatitis 3

Interventions

Levetiracetam 6 Cannabidiol 4 perampanel 2 Standard of Care 2 Everolimus 2 enzalutamide 1 Vigabatrin 1 Tranexamic Acid 1 Temozolomide 1 Sodium Chloride 1 Saline Solution 1 Pregabalin 1 Medical Marijuana 1 Magnesium Sulfate 1 Drug Therapy 1 Curcumin 1 Cholecalciferol 1 Aspirin 1 Anticonvulsants 1 Anastrozole 1 Airway Extubation 1 2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Seizures × Saline Solution × Clear all

NCT04595786 2025-03-04

STAMP

Beijing Tiantan Hospital

Phase NA Completed

Meningioma, Seizures

Data powered by HemOnc (CC BY 4.0) Colophon ⚡